Tactile Systems Technology Inc

Tactile Systems Technology Inc

TCMD · NASDAQ · Healthcare / Medical Devices

26.81USD-0.01 (-0.04%)

Price History

Full chart

Market Stats

Previous Close26.82
Open26.85
Day Range26.47 – 27.15
52-Week Range13.48 – 37.77
Volume169.92K
Market Cap514.89M
P/E (TTM)20.85
Forward P/E19.12
EPS1.09
Dividend Yield0.00%
Beta0.79
50-Day Avg24.99
200-Day Avg26.71

About

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Sheri Louise Dodd
  • Employees1.09K
  • Headquarters3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416, USA
  • Websitehttps://tactilemedical.com

Leadership

  • Ms. Sheri Louise DoddCEO, President & Director · b. 1966
  • Ms. Elaine M. BirkemeyerChief Financial Officer · b. 1975
  • Ms. Kristie T. BurnsSenior Vice President of Business Development · b. 1972
  • Ben AmelChief Information Officer
  • Ms. Sunday J. Hoy Esq.VP of Regulatory Affairs & Chief Compliance Officer
  • Aaron R. SnodgrassSenior Vice President of Sales
  • Mr. Nicolaus B. WilsonSenior Vice President of Marketing & Market Access
  • Janelle M. StropChief Human Resource Officer
  • Dr. Antonios P. Gasparis F.A.C.S., M.D.Chief Medical Officer & Member of Vascular Strategic Advisory Board

Financials

Income Statement

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue37.18M47.74M62.87M84.54M109.28M143.75M189.49M187.13M208.06M246.78M274.42M292.98M329.52M
Growth (%)-+28.41%+31.71%+34.47%+29.26%+31.54%+31.82%-1.25%+11.18%+18.61%+11.20%+6.76%+12.47%
Cost of Revenue9.77M12.71M16.91M22.94M29.02M41.49M55.26M54.32M59.84M70.81M79.29M76.30M81.82M
Gross Profit27.40M35.02M45.96M61.60M80.27M102.26M134.24M132.81M148.21M175.98M195.13M216.69M247.70M
Gross Margin73.71%73.36%73.11%72.87%73.45%71.14%70.84%70.97%71.24%71.31%71.11%73.96%75.17%
Operating Expense25.02M31.22M42.51M57.33M76.37M99.27M123.74M136.44M149.97M188.73M177.09M194.51M218.42M
Operating Income2.38M3.80M3.45M4.27M3.90M2.99M10.50M-3.63M-1.76M-12.76M18.04M22.18M29.28M
Operating Margin6.40%7.96%5.49%5.05%3.57%2.08%5.54%-1.94%-0.85%-5.17%6.57%7.57%8.89%
EBITDA2.96M4.50M4.28M5.07M3.90M2.99M14.04M-834.00K1.39M1.75M26.42M32.37M39.02M
EBITDA Margin7.98%9.44%6.80%6.00%3.57%2.08%7.41%-0.45%0.67%0.71%9.63%11.05%11.84%
Net Income3.16M2.07M1.39M2.88M5.86M6.62M10.97M-620.00K-11.81M-17.87M28.52M16.96M19.09M
Net Income Margin8.49%4.34%2.22%3.41%5.36%4.61%5.79%-0.33%-5.68%-7.24%10.39%5.79%5.79%
R&D2.44M2.84M4.31M4.48M5.06M5.29M5.17M5.26M5.66M7.09M7.82M8.83M8.48M
R&D as % of Total Revenue6.57%5.96%6.86%5.29%4.63%3.68%2.73%2.81%2.72%2.87%2.85%3.01%2.57%
Interest Expense000000631.00K1.37M531.00K2.79M4.15M2.08M1.04M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.33%0.73%0.26%1.13%1.51%0.71%0.32%

Balance Sheet

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets29.23M31.49M36.97M73.94M88.45M107.07M151.75M174.09M244.27M255.00M281.44M297.92M273.94M
Total Liabilities7.02M6.84M9.70M14.30M15.66M17.80M39.16M49.34M116.04M133.60M87.80M81.33M55.04M
Total Equity22.21M24.66M27.28M59.64M72.79M89.27M112.59M124.75M128.23M121.40M193.64M216.60M218.90M
Cash6.54M5.42M7.06M30.70M23.97M20.10M22.77M47.85M28.23M21.93M61.03M94.37M83.45M
Total Debt22.00K13.00K991.00K67.00K17.00K5.00K16.59M21.39M80.61M72.23M50.38M45.11M15.96M
Net Debt-6.52M-5.40M-6.07M-30.63M-23.95M-20.09M-6.18M-26.46M52.38M50.30M-10.66M-49.26M-67.49M

Cash Flow

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-425.00K-991.00K1.36M7.03M4.19M9.01M2.51M2.79M2.63M5.21M35.85M40.66M42.81M
Investing Cash Flow-364.00K-353.00K-615.00K-11.84M-14.02M-14.73M-2.33M20.18M-82.18M-1.91M-2.48M-2.50M-2.54M
Financing Cash Flow-2.08M221.00K901.00K28.45M3.09M1.85M2.50M2.11M59.93M-9.60M5.73M-4.82M-51.20M
Capital Expenditure364.00K353.00K615.00K833.00K3.82M9.55M5.99M2.29M2.35M1.92M2.48M2.51M2.38M
Free Cash Flow-789.00K-1.34M743.00K6.20M372.00K-539.00K-3.48M503.00K276.00K3.29M33.37M38.15M40.43M
Dividends Paid-8.21M8.21M8.21M00--61.10M1.44M8.26M--
FCF to OCF185.65%135.62%54.71%88.16%8.87%-5.98%-138.57%18.00%10.49%63.14%93.08%93.83%94.44%
Dividend Paid to FCF--610.64%1104.58%132.37%0.00%0.00%--22137.68%43.75%24.76%--

Earnings

Report DateSep 7, 2016Nov 10, 2016Feb 27, 2017May 8, 2017Aug 7, 2017Nov 7, 2017Feb 26, 2018May 7, 2018Aug 6, 2018Nov 5, 2018Feb 28, 2019May 6, 2019Aug 5, 2019Nov 4, 2019Feb 26, 2020May 4, 2020Aug 3, 2020Nov 2, 2020Feb 23, 2021May 3, 2021Aug 2, 2021Nov 8, 2021Feb 22, 2022May 2, 2022Aug 1, 2022Nov 7, 2022Feb 21, 2023May 8, 2023Aug 7, 2023Nov 6, 2023Feb 20, 2024May 6, 2024Aug 5, 2024Nov 4, 2024Feb 18, 2025May 5, 2025Aug 4, 2025Nov 3, 2025Feb 18, 2026May 4, 2026Aug 10, 2026Nov 2, 2026
EPS Estimate0.040.010.04-0.160.010.050.13-0.140.030.080.14-0.060.080.110.27-0.02-0.23-0.060.24-0.190.020.120.05-0.20-0.07-0.050.14-0.20-0.020.020.19-0.010.140.170.28-0.060.140.210.45-0.040.140.29
EPS Actual0.070.010.13-0.090.040.070.12-0.000.070.090.250.080.140.120.26-0.05-0.720.120.55-0.120.07-0.17-0.28-0.42-0.150.090.23-0.030.040.850.35-0.050.200.250.40-0.110.140.360.460.000.34-
Surprise75.00%0.00%225.00%43.75%300.00%40.00%-7.69%98.00%133.33%12.50%78.57%233.33%75.00%9.09%-3.70%-150.00%-213.04%300.00%129.17%36.84%250.00%-241.67%-660.00%-110.00%-114.29%280.00%64.29%85.00%300.00%4150.00%84.21%-400.00%42.86%47.06%41.79%-83.33%0.00%71.43%3.37%106.00%142.86%-
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap514.89M
Enterprise Value437.67M
Trailing P/E20.85
Forward P/E19.12
PEG Ratio17.79
Price / Sales1.47
Price / Book2.27
EPS1.09
Book Value9.86
Revenue (TTM)350.31M
Gross Profit (TTM)268.97M
EBITDA41.74M
Profit Margin7.10%
Operating Margin7.97%
Return on Equity11.88%
Return on Assets7.92%
Shares Outstanding22.65M
Shares Float20.58M
Beta0.79
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 5 analystsTarget 39.00
  • Strong Buy
    1
  • Hold
    4

Ownership Breakdown

Institutions
105.01%
Insiders
2.25%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    1.78M7.86%
  • Cadian Capital Management LP
    1.58M6.96%
  • Morgan Stanley - Brokerage Accounts
    1.38M6.10%
  • Dimensional Fund Advisors, Inc.
    1.09M4.82%
  • Vanguard Capital Management, LLC
    945.10K4.17%
  • Acadian Asset Management LLC
    905.37K4.00%
  • Driehaus Capital Management LLC
    741.91K3.28%
  • Federated Hermes Inc
    681.15K3.01%
  • Vanguard Portfolio Management, LLC
    668.33K2.95%
  • Arrowstreet Capital Limited Partnership
    638.37K2.82%
  • Deutsche Bank AG
    580.81K2.56%
  • State Street Corp
    568.43K2.51%
  • Geode Capital Management, LLC
    556.79K2.46%
  • Renaissance Technologies Corp
    510.90K2.26%
  • Next Century Growth Investors LLC
    480.21K2.12%
  • LSV Asset Management
    479.93K2.12%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    686.53K3.03%
  • iShares Russell 2000 ETF
    589.49K2.60%
  • Xtrackers MSCI World Swap ETF 1C
    540.69K2.39%
  • Janus Henderson Small Cap Value L
    485.42K2.14%